Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older.

Clinical trial NCT07582796 · RECRUITING

Trial details

NCT number: NCT07582796
Sponsor: Ab&B Bio-tech Co., Ltd.JS
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2026-05-14
Primary completion: 2027-09-14
Enrollment: 470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.